Overview

A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Study in Healthy Volunteers to Assess the Pharmacokinetics of Metformin Administered Alone and In Combination with Vandetanib
Phase:
Phase 1
Details
Lead Sponsor:
Sanofi
Treatments:
Metformin